Erratum: A selective and brain penetrant p38αMAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction (J. Med. Chem. (2019) 62:11 (5298-5311) DOI: 10.1021/acs.jmedchem.9b00058)

Saktimayee M. Roy, George Minasov, Ottavio Arancio, Laura W. Chico, Linda J. van Eldik, Wayne F. Anderson, Jeffrey C. Pelletier, D. Martin Watterson

Research output: Contribution to journalComment/debate

Abstract

In Figure 7, the units of the y axis should be “μg/mL” instead of “mg/mL”.

Original languageEnglish
Pages (from-to)8649
Number of pages1
JournalJournal of Medicinal Chemistry
Volume63
Issue number15
DOIs
StatePublished - Aug 13 2020

Bibliographical note

Publisher Copyright:
© 2020 American Chemical Society. All rights reserved.

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Erratum: A selective and brain penetrant p38αMAPK inhibitor candidate for neurologic and neuropsychiatric disorders that attenuates neuroinflammation and cognitive dysfunction (J. Med. Chem. (2019) 62:11 (5298-5311) DOI: 10.1021/acs.jmedchem.9b00058)'. Together they form a unique fingerprint.

Cite this